|
TTC21B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69609992717312E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.65160165730572E-11 |
| Normal-vs-Stage2 |
1.269670E-02 |
| Normal-vs-Stage3 |
3.357900E-03 |
| Normal-vs-Stage4 |
7.415600E-02 |
| Stage1-vs-Stage2 |
4.577200E-01 |
| Stage1-vs-Stage3 |
6.912100E-02 |
| Stage1-vs-Stage4 |
1.564540E-03 |
| Stage2-vs-Stage3 |
5.831400E-01 |
| Stage2-vs-Stage4 |
1.893380E-01 |
| Stage3-vs-Stage4 |
2.912000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.397904676689E-11 |
| Normal-vs-AfricanAmerican |
2.878600E-01 |
| Normal-vs-Asian |
1.050040E-01 |
| Caucasian-vs-AfricanAmerican |
8.522800E-03 |
| Caucasian-vs-Asian |
8.935000E-01 |
| AfricanAmerican-vs-Asian |
2.186800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.595500E-04 |
| Normal-vs-Female |
3.39950290140223E-13 |
| Male-vs-Female |
2.91740000046836E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.212200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.02880000074634E-08 |
| Normal-vs-Age(61-80Yrs) |
6.40799999951369E-07 |
| Normal-vs-Age(81-100Yrs) |
7.318000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.180110E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.827900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.597500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.647800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.998600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.625800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.276160E-03 |
| Normal-vs-Grade 2 |
6.66300348228788E-12 |
| Normal-vs-Grade 3 |
2.08199999999215E-05 |
| Normal-vs-Grade 4 |
4.873400E-01 |
| Grade 1-vs-Grade 2 |
5.171800E-01 |
| Grade 1-vs-Grade 3 |
1.063040E-01 |
| Grade 1-vs-Grade 4 |
1.429560E-04 |
| Grade 2-vs-Grade 3 |
1.580270E-02 |
| Grade 2-vs-Grade 4 |
8.96420004892207E-09 |
| Grade 3-vs-Grade 4 |
2.193100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
4.137600E-01 |
| ccA subtype-vs-ccB subtype |
1.62436730732907E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.52390000407854E-08 |
| Normal-vs-N1 |
4.704600E-01 |
| N0-vs-N1 |
3.692500E-02 |
|
|
